VKH
EVH icon

Virtu KCG Holdings’s Evolent Health EVH Stock Holding History

Virtu KCG Holdings’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-15,220
Closed -$339K – 3031
2017
Q1 		$339K Sell
15,220
-946
-6% -$18.2K 0.01% 1787
2016
Q4 		$239K Buy
+16,166
New +$319K 0.01% 2367
2015
Q4 		– Sell
-14,082
Closed -$225K – 3602
2015
Q3 		$225K Buy
14,082
+1,630
+13% +$31.8K ﹤0.01% 2442
2015
Q2 		$243K Buy
+12,452
New +$232K ﹤0.01% 2343

Other funds holding EVH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Virtu KCG Holdings's EVH Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Evolent Health (EVH) in Q2 2017, closing a stake of 15,220 shares — an estimated $339K sold.

Virtu KCG Holdings first reported a position in EVH in Q2 2015 and held it in 4 quarters. The position peaked at $339K in Q1 2017. 167 funds tracked by Wall St. Rank hold EVH as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Evolent Health position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 15,220 Evolent Health shares in Q2 2017, an estimated $339K.
  • Virtu KCG Holdings first reported a position in Evolent Health in Q2 2015 and held it in 4 quarters.
  • Virtu KCG Holdings's Evolent Health position peaked at $339K in Q1 2017.
  • 167 funds tracked by Wall St. Rank held Evolent Health as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.